Member Info for DeBull

However, goes out on RNS Reach.

https://www.londonstockexchange.com/news-article/PYC/contract-award/16317341

Someone put on X yesterday https://x.com/Physiomics/status/1750891752691572852?s=20 Although i guess Eli are a big name, this poster is from 2010! Over 13 years ago. 1 of the lead names ( erik ) does not work at PYC anymore. Why would you put something out that is 13+ yrs old?

Is there precedent for a IM for board changes on AIM?

Maybe its a kind of sweep the decks, start a fresh thing?

I know KHJ was tongue in cheek about the directorship of Peter, but is this also common within AIM that a CEO is not (yet) a director? Corn,Kumar,Millen & Chassagnole are.

Nearly 1m in buys v 300k in sells and down.

After 800k v 200k buy v sell it is now back to where it started.

Not sure if this link will work, but it goes back to 2021, look at the Oncology drugs, no mention of Docetaxel ( even thou Physiomics & Doseme have been partners since 2019 i think ) http://web.archive.org/web/20210614032948/https://doseme-rx.com/why-dosemerx/drug-packages

Thank you KHJ, this is the first time Docetaxel has been on the Doseme website. Maybe there is some movement in the Doseme/PYC partnership after all?

Yesterday, the RNS said this "During this presentation, Jim Millen CEO and Peter Sargent would be happy to take questions relating to the changes announced yesterday. "

Yet at the bottom it stated Peter was the Chief executive officer.

Looks like they can not get the basics right, or whoever scrutinises these RNS's missed it?

I dont think what Share4 asked re stepping down is so wrong? Its a perfectly valid question? Last week someone on here said that funds from a share sale could be used because of a medical condition? You never know, Jim may have a condition, and wishes to take a back seat? I think any eventuality should be looked at regarding the board move today?

Porky, did you ever watch "Soap" if so, your post is very much like their opening sequence.

Peterm was the cougher.

Are we to expect a new COO now? Remember Chris was in that role & left it, hence Peters arrival. Now Peter is new CEO, the COO is not again operational?

Https://www.londonstockexchange.com/news-article/PYC/board-changes/16297513

Interseting turn if events.

Many have called for Jim Millen to be removed.

My first question is, will Peter be buying a substantial amount of stock to back these " I can see many exciting opportunities ahead for us. I look forward to speaking to shareholders next week and over the course of 2024."

Project Optimus seeks to improve the dose optimisation and dose selection paradigm in #oncology #drugdevelopment. The focus is on conducting these studies as early as possible in the #drugdevelopment process. 👇 https://fda.gov/about-fda/oncology-center-excellence/project-optimus #pharma

My critism on this post is they do not put hash tag # in front of Project Optimus and there is no #PYC

I thought that thursday we ended flat, and Friday we ended in positive territory, so where was the 2 consequective blue days?

KJH i read your reply to the Project Optimus post, and i agree 100% with everything you stated.

PYC tweeted about Project Optimus again yesteday, it does seem they are trying to get that particular FDA band wagon rolling?

Laura, i did say ot was a old wives tale regarding the 1 code? We've had numerous now 1 trades, and no RNS so yep, its rubbish.

a trade of 100 or 200 is also a old wives tale regarding MM's secret codes, probably bunkum to.

PYC did tweet or X or whatever you cal it now and mentioned Project Optimus

https://www.imperial.ac.uk/advanced-therapeutics-centre/

https://advancedtherapeutics.org.uk/

https://www.mewburn.com/spotlight-on-advanced-therapeutics

https://mkainsights.com/insights/biotech-pharma-healthcare/what-are-advanced-therapies/

Its indeed unbelieveable that people have been arguing if the 250k was a buy or sell. I thought it was a sell myself as the price went down shortly afterwards.

Its also unbelieveable that this site has the price down over 14% when it should be uder 3%

People buying just 1 share, or as the old fable suggests, a trade value of 1 showing says a RNS is due, there was a trade of a 100 which another fable for some kind of market maker code.

Freudian slip on the headline Laura :-) AI could be a gold mine.

I like the final sentence “These themes include precision medicine, genetic medicine, cell therapy, immunotherapy, synthetic biology, and artificial intelligence"

However, for any of this GMS $ to get to PYC or to any of the companies that use their service remains a very long shot.

The tweet that they put out and said "Here's to a year full of growth! 🥂" I just hope they do not mean growth in finacial losses, or growth in shareholder's losses.